Journal
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE
Volume 8, Issue 2, Pages 63-64Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1753465814521890
Keywords
chronic obstructive pulmonary disease; high-flow nasal oxygen; hypercarbic respiratory failure; noninvasive ventilation; type II respiratory failure
Categories
Ask authors/readers for more resources
Hypercarbic respiratory failure, occurring secondary to chronic lung disease, is a frequently encountered problem. These patients present a significant challenge to respiratory and critical care services, as many are unsuitable for mechanical ventilation and most have multiple comorbidities. Recently, noninvasive ventilation (NIV) has become established as the primary modality for respiratory support in this group of patients. Several factors limit patient compliance with NIV, not least comfort and tolerability. A recent innovation in adult critical care is the use of high-flow nasal oxygen (HFNO) devices. These systems are capable of delivering high gas flows via nasal cannulae, with the ability to blend air and oxygen to give a controlled FiO(2). Few clinical studies have been conducted in adults, although several are planned. To date the majority of available evidence addresses the use of HFNO in hypoxemic respiratory failure. Here we present a case in which a HFNO system was used to successfully manage hypercarbic respiratory failure in a patient unable to tolerate conventional NIV.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available